These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868 [TBL] [Abstract][Full Text] [Related]
24. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Khan AB; Barrington SF; Mikhaeel NG; Hunt AA; Cameron L; Morris T; Carr R Blood; 2013 Jul; 122(1):61-7. PubMed ID: 23660958 [TBL] [Abstract][Full Text] [Related]
25. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases. Büyükşimşek M; Kolsuz İ; Yetişir AE; Tohumcuoğlu M; Oğul A; Mirili C; Paydaş S; Güney İB Turk J Haematol; 2020 Nov; 37(4):220-225. PubMed ID: 32003552 [TBL] [Abstract][Full Text] [Related]
26. Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma. St-Pierre F; Broski SM; LaPlant BR; Maurer MJ; Ristow K; Thanarajasingam G; Macon WR; Habermann TM; Witzig TE Oncologist; 2020 Aug; 25(8):689-695. PubMed ID: 32319706 [TBL] [Abstract][Full Text] [Related]
27. Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era. Jelicic J; Hansen DL; Carlsen SS; Thorsgaard M; Hersby DS; Kannik K; Munksgaard ASE; Larsen TS; Juul-Jensen K Ann Hematol; 2023 Jul; 102(7):1897-1905. PubMed ID: 37246974 [TBL] [Abstract][Full Text] [Related]
28. Assessing bone marrow involvement in diffuse large B-cell lymphoma with 18F-FDG PET/CT: A preliminary experience at Hospital Pulau Pinang. Siti Maisarah MN; Mahayuddin AM; Fadzilah H Med J Malaysia; 2021 Sep; 76(5):665-671. PubMed ID: 34508372 [TBL] [Abstract][Full Text] [Related]
29. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy. Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937 [TBL] [Abstract][Full Text] [Related]
30. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma. Arslantaş E; Ayçiçek A; Akıcı F; Özkara S; Yılmaz B; Özdemir N; Bayram C Nuklearmedizin; 2023 Feb; 62(1):20-26. PubMed ID: 36746148 [TBL] [Abstract][Full Text] [Related]
31. The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement. Jackson AE; Smeltzer JP; Habermann TM; Jones JM; Burnette B; Ristow K; Wiseman GA; Macon WR; Nowakowski GS; Witzig TE Am J Hematol; 2014 Sep; 89(9):865-7. PubMed ID: 24823914 [TBL] [Abstract][Full Text] [Related]
32. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials. Kaddu-Mulindwa D; Altmann B; Held G; Angel S; Stilgenbauer S; Thurner L; Bewarder M; Schwier M; Pfreundschuh M; Löffler M; Menhart K; Grosse J; Ziepert M; Herrmann K; Dührsen U; Hüttmann A; Barbato F; Poeschel V; Hellwig D Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3550-3559. PubMed ID: 33928400 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. Aide N; Talbot M; Fruchart C; Damaj G; Lasnon C Eur J Nucl Med Mol Imaging; 2018 May; 45(5):699-711. PubMed ID: 29214417 [TBL] [Abstract][Full Text] [Related]
34. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma. Albano D; Patti C; Lagalla R; Midiri M; Galia M J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267 [TBL] [Abstract][Full Text] [Related]
36. The Diagnostic Accuracy of Bone Marrow Biopsy Versus PET/CT Scan in Identifying Bone Marrow Involvement in Diffuse Large B Cell Lymphoma Patients at a Cancer Hospital. Asif H; Zubair R; Siddiqui IA; Tariq Mahmood M; Jamil A; Tahir A Cureus; 2023 Feb; 15(2):e34901. PubMed ID: 36938170 [TBL] [Abstract][Full Text] [Related]
37. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using Hao B; Zhao L; Luo NN; Ruan D; Pang YZ; Guo W; Fu H; Guo XY; Luo ZM; Wu J; Chen HJ; Wu H; Sun L BMC Cancer; 2018 Nov; 18(1):1192. PubMed ID: 30497426 [TBL] [Abstract][Full Text] [Related]
38. Bone marrow involvement in pediatric malignancies: a comparison study of Positron emission tomographycomputed tomography and bone marrow biopsy. Tezol Ö; Sağcan F; Özcan PP; Çıtak EÇ Turk J Pediatr; 2020; 62(2):182-190. PubMed ID: 32419409 [TBL] [Abstract][Full Text] [Related]
39. Staging DLBCL: bone marrow biopsy or PET-CT? Avigdor A Blood; 2013 Jul; 122(1):4-5. PubMed ID: 23828884 [TBL] [Abstract][Full Text] [Related]
40. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]